Overview
This page compares Chainlink and Injective with live PEPS metrics. Rankings (#19 vs #99) and liquidity profiles differ, so traders often use them for distinct roles rather than as perfect substitutes.
Quick winners
Full comparison
| Metric | LINK | INJ |
|---|---|---|
| Price | $8.29 | $4.98 |
| Market Cap | $6.30B | $490.41M |
| FDV | — | — |
| Volume 24h | $11.34M | $2.75M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 19.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +4.13% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | LINK | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +2.17% | +1.20% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | LINK | INJ |
|---|---|---|
| RSI | 45.39 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.33 | 0.29 |
| ADX | 14.96 | 12.19 |
| Support | 8.20 | 4.91 |
| Resistance | 8.73 | 5.07 |
| Trend | neutral | neutral |
| Momentum | — | — |
| Signal | neutral | neutral |
Automatic technical analysis
Use the indicator table as a checklist: if momentum and trend align on one asset while the other diverges, relative-value setups become more interesting — still without certainty.
Fundamentals
| Metric | LINK | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 87.00 | 0.00 |
| Github activity | 5,703.00 | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Chainlink
Injective
Pros and cons
Pros of Chainlink
- Chainlink has an established coin page footprint on PEPS for continuous monitoring.
- Market-cap scale on Chainlink may dampen some idiosyncratic shocks versus smaller peers.
- Composite PEPS readings for Chainlink can surface clearer module agreement during trend phases.
Cons of Chainlink
- When dominance narratives fade, Chainlink can lag hotter rotation names.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Large-cap status for Chainlink can mean slower percentage upside versus high-beta alternatives.
Pros of Injective
- Active volume bursts on INJ sometimes precede sharper tactical moves.
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- If technical momentum aligns, Injective may outperform on medium-term windows.
- Diversifying versus Chainlink with Injective can change portfolio factor exposure.
Cons of Injective
- Smaller book depth versus large caps can increase slippage for Injective.
- Trend failures on Injective often travel faster than on more established assets.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
Which looks stronger right now?
Statistically, higher market cap (Chainlink) often correlates with deeper books, while hotter 24h prints (Chainlink) can fade. Position sizing should reflect that uncertainty.
AI summary
For readers asking which is “better”, the honest answer is conditional. Chainlink and Injective solve overlapping but not identical market jobs. On-chain and developer fields, when available, add slower-moving context beneath the tape. Missing fundamentals should be treated as unknown, not as zeros. If your thesis is long-term adoption, weight fundamentals and liquidity; if tactical, weight trend/momentum — and always define invalidation.
FAQ
Which is better, Chainlink or Injective?
“Better” depends on horizon and risk. Chainlink leads on market cap today, while Chainlink leads the 24h move — neither is a guarantee.
Which has more upside potential, LINK or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Chainlink and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Chainlink currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Chainlink, but longer windows can disagree.